| Recombineering: a homologous recombination-based method of genetic engineering SK Sharan, LC Thomason, SG Kuznetsov, DL Court Nature protocols 4 (2), 206-223, 2009 | 995 | 2009 |
| Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds J Zimmer, EMC Tacconi, C Folio, S Badie, M Porru, K Klare, M Tumiati, ... Molecular cell 61 (3), 449-460, 2016 | 228 | 2016 |
| A handcuff model for the cohesin complex N Zhang, SG Kuznetsov, SK Sharan, K Li, PH Rao, D Pati The Journal of cell biology 183 (6), 1019-1031, 2008 | 214 | 2008 |
| Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2 SG Kuznetsov, P Liu, SK Sharan Nature medicine 14 (8), 875-881, 2008 | 159 | 2008 |
| VIPER: an industrially scalable high-current high-temperature superconductor cable ZS Hartwig, RF Vieira, BN Sorbom, RA Badcock, M Bajko, WK Beck, ... Superconductor Science and Technology 33 (11), 11LT01, 2020 | 153 | 2020 |
| RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females S Kuznetsov, M Pellegrini, K Shuda, O Fernandez-Capetillo, Y Liu, ... The Journal of cell biology 176 (5), 581-592, 2007 | 149 | 2007 |
| Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice SG Kuznetsov, DC Haines, BK Martin, SK Sharan Cancer research 69 (3), 863-872, 2009 | 107 | 2009 |
| High prevalence and breast cancer predisposing role of the BLM c. 1642 C> T (Q548X) mutation in Russia AP Sokolenko, AG Iyevleva, EV Preobrazhenskaya, NV Mitiushkina, ... International Journal of Cancer 130 (12), 2867-2873, 2012 | 105 | 2012 |
| A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell–based assay K Biswas, R Das, BP Alter, SG Kuznetsov, S Stauffer, SL North, S Burkett, ... Blood, The Journal of the American Society of Hematology 118 (9), 2430-2442, 2011 | 64 | 2011 |
| Role of epithelial cells and programmed cell death in Hydra spermatogenesis S Kuznetsov, M Lyanguzowa, TCG Bosch Zoology 104 (1), 25-31, 2001 | 55 | 2001 |
| Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers AP Sokolenko, EL Savonevich, AO Ivantsov, GA Raskin, ES Kuligina, ... Cancer letters 397, 127-132, 2017 | 49 | 2017 |
| Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant L Li, K Biswas, LA Habib, SG Kuznetsov, N Hamel, T Kirchhoff, N Wong, ... Human mutation 30 (11), 1543-1550, 2009 | 40 | 2009 |
| High prevalence of GPRC5A germline mutations in BRCA1‐mutant breast cancer patients AP Sokolenko, DR Bulanova, AG Iyevleva, SN Aleksakhina, ... International journal of cancer 134 (10), 2352-2358, 2014 | 38 | 2014 |
| Resolving RAD51C function in late stages of homologous recombination SK Sharan, SG Kuznetsov Cell Division 2, 1-9, 2007 | 33 | 2007 |
| Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation ES Kuligina, AP Sokolenko, NV Mitiushkina, SN Abysheva, ... Familial cancer 12, 129-132, 2013 | 32 | 2013 |
| Epithelial interactions in Hydra: apoptosis in interspecies grafts is induced by detachment from the extracellular matrix SG Kuznetsov, F Anton-Erxleben, TCG Bosch Journal of experimental biology 205 (24), 3809-3817, 2002 | 30 | 2002 |
| The SPARC toroidal field model coil program ZS Hartwig, RF Vieira, D Dunn, T Golfinopoulos, B LaBombard, CJ Lammi, ... IEEE Transactions on Applied Superconductivity, 2023 | 25 | 2023 |
| Suppression of BRCA1 sensitizes cells to proteasome inhibitors Y Gu, P Bouwman, D Greco, J Saarela, B Yadav, J Jonkers, ... Cell death & disease 5 (12), e1580-e1580, 2014 | 24 | 2014 |
| Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications S Philip, S Swaminathan, SG Kuznetsov, S Kanugula, K Biswas, S Chang, ... Cancer research 68 (23), 9973-9981, 2008 | 24 | 2008 |
| BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine Y Gu, M Helenius, K Väänänen, D Bulanova, J Saarela, A Sokolenko, ... Scientific Reports 6 (1), 28217, 2016 | 23 | 2016 |
Kajal BiswasNational Institutes of HealthVerified email at mail.nih.gov
